Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Connective Tissue Related ILD”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Post-approval studies (Phase 4)Looking for participantsNCT07077486
What this trial is testing

Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease

Who this might be right for
Lupus or SLEInterstitial Lung DiseaseSystemic Lupus Erythematosus
Tongji Hospital 100
Large-scale testing (Phase 3)Study completedNCT02990286
What this trial is testing

Evaluation of Efficacy and Safety of Rituximab With Mycophenolate Mofetil in Patients With Interstitial Lung Diseases

Who this might be right for
Lung Disease, Interstitial
University Hospital, Tours 122
Not applicableUnknownNCT00006055
What this trial is testing

Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases

Who this might be right for
Purpura, Schoenlein-HenochGraft Versus Host DiseaseAnemia, Hemolytic, Autoimmune+11 more
Fairview University Medical Center 10
Not applicableStudy completedNCT05894317
What this trial is testing

Vascular Access Complications for Therapeutic Apheresis in Nephrology

Who this might be right for
Vascular Access ComplicationApheresis Related Complication
Central Hospital, Nancy, France 60
Post-approval studies (Phase 4)Looking for participantsNCT07319598
What this trial is testing

Test Tetrandrine Tablets for Connective Tissue Disease-Related Lung Disease

Who this might be right for
Interstitial Lung Disease (ILD)Connective Tissue Disease-associated Interstitial Lung Disease
Peking University Third Hospital 100
Large-scale testing (Phase 3)Study completedNCT02597933
What this trial is testing

A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis

Who this might be right for
Scleroderma, Systemic
Boehringer Ingelheim 580
Large-scale testing (Phase 3)UnknownNCT00896155
What this trial is testing

Trial of Concurrent Versus Sequential Tamoxifen With Radiotherapy in Breast Cancer Patients

Who this might be right for
Pulmonary FibrosisBreast Cancer
Tata Memorial Hospital 260
Post-approval studies (Phase 4)UnknownNCT04928586
What this trial is testing

Immunosuppressant Combined With Pirfenidone in CTD-ILD

Who this might be right for
PirfenidoneConnective Tissue DiseasesInterstitial Lung Disease
Qilu Hospital of Shandong University 200
Not applicableLooking for participantsNCT07174102
What this trial is testing

Radiologic Features of Rheumatoid Arthritis Interstitial Lung Disease at Chest High Resolution Computed Tomography

Who this might be right for
Reumatoid ArthritisInterstitial Lung Disease Due to Systemic Disease (Disorder)Idiopathic Pulmonary Fibrosis (IPF)+1 more
Azienda Unita Sanitaria Locale di Piacenza 500
Testing effectiveness (Phase 2)UnknownNCT05246293
What this trial is testing

Tofacitinib in the Treatment of Rheumatoid Arthritis-related Interstitial Lung Disease.

Who this might be right for
Rheumatoid ArthritisInterstitial Lung Disease
National Institute of Respiratory Diseases, Mexico 60
Testing effectiveness (Phase 2)Looking for participantsNCT05892614
What this trial is testing

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

Who this might be right for
Interstitial Lung Disease
aTyr Pharma, Inc. 25
Testing effectiveness (Phase 2)Study completedNCT00883129
What this trial is testing

Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)

Who this might be right for
SclerodermaInterstitial Lung Disease
Michael Roth 142
Large-scale testing (Phase 3)Study completedNCT02896205
What this trial is testing

Study to Compare the Efficacy of Mycophenolate Mofetil in Systemic Sclerosis Related Early Interstitial Lung Disease

Who this might be right for
Systemic SclerosisSclerodermaInterstitial Lung Disease
Post Graduate Institute of Medical Education and Research, Chandigarh 41
Testing effectiveness (Phase 2)Ended earlyNCT04837131
What this trial is testing

Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients

Who this might be right for
Systemic SclerosisSclerodermaDiffuse Systemic Sclerosis+16 more
Michael M. Pham 4
Not applicableStudy completedNCT00001473
What this trial is testing

Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides

Who this might be right for
VasculitisWegener's Granulomatosis
National Institute of Allergy and Infectious Diseases (NIAID) 100
Testing effectiveness (Phase 2)Study completedNCT01933334
What this trial is testing

Safety and Tolerability of Pirfenidone in Participants With Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)

Who this might be right for
Systemic Sclerosis
Genentech, Inc. 63
Not applicableLooking for participantsNCT06696027
What this trial is testing

AYLo - AutoimmunitY and Loss of y

Who this might be right for
Giant Cell Arteritis (GCA)Polymyalgia Rheumatica (PMR)ANCA Associated Vasculitis (AAV)+10 more
University of Bonn 500
Not applicableStudy completedNCT03300583
What this trial is testing

Toward Self-management in ILD

Who this might be right for
Interstitial Lung DiseaseIdiopathic Pulmonary FibrosisConnective Tissue Related ILD+2 more
Kingston University 16
Post-approval studies (Phase 4)UnknownNCT05505409
What this trial is testing

Efficacy and Safety of Pirfenidone in CTD-ILD

Who this might be right for
PirfenidoneConnective Tissue DiseasesInterstitial Lung Disease
Qilu Hospital of Shandong University 120
Testing effectiveness (Phase 2)Study completedNCT03221257
What this trial is testing

Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate

Who this might be right for
Scleroderma, SystemicInterstitial Lung Disease
Michael Roth 51
Load More Results